Menu
ETF
Annual · values2025202420232022
Operating Cash Flow-7.41 M USD-6.07 M USD-5.77 M USD-3.64 M USD
Depreciation & Amortization37599 USD27892 USD26915 USD26566 USD
Stock-Based Compensation249884 USD405025 USD248308 USD68396 USD
Capital Expenditures3157 USD64455 USD18308 USD1932 USD
Cash Flow from Investing-30188 USD-125271 USD-18308 USD-1932 USD
Cash Flow from Financing2.73 M USD10.34 M USD6.53 M USD3.84 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-7.42 M USD-6.13 M USD-5.79 M USD-3.65 M USD

HeartSciences Inc. is a healthcare company that specializes in the development and commercialization of innovative medical diagnostic solutions. Its primary focus is on cardiac care, aiming to improve the early detection and monitoring of heart disease through advanced technology. HeartSciences is particularly noted for its software-based platform that enhances the capabilities of existing electrocardiogram (ECG) devices by using signal processing and AI-driven algorithms. This enhancement provides medical practitioners with a more detailed analysis of heart conditions, potentially leading to more accurate diagnoses. The company's solutions are designed to be cost-effective and accessible, targeting a range of healthcare facilities, from large hospitals to smaller clinics. HeartSciences is part of the medical technology industry, contributing to the growing field of digital health innovations. By integrating its technology into routine cardiac evaluations, HeartSciences seeks to play a significant role in preventative healthcare and in reducing the burden of cardiovascular diseases globally.